Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-11

Clinical Trial Update: Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a Phase 2/3 trial of a capsaicin nanoparticle for Painful Diabetic Neuropathy, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capsaicin nanoparticle (capsaicin nanoparticle)

Snippet

Sponsor: Mahidol University | Conditions: Painful Diabetic Neuropathy | Phase 2, Phase 3 | Status: UNKNOWN